Ranking the role of RANK ligand in apoptosis

被引:41
|
作者
Bharti, AC
Aggarwal, BB
机构
[1] Univ Texas, MD Anderson Canc Ctr, Cytokine Res Sect, Dept Expt Therapeut, Houston, TX 77030 USA
[2] ICMR, Inst Cytol & Prevent Oncol, Noida, Uttar Pradesh, India
关键词
Akt; apoptosis; cell cycle arrest; JNK; NF-kappa B; PI3Kinase; RANK; RANKL; TRAF6;
D O I
10.1023/B:APPT.0000045780.10463.c6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many members of tumor necrosis factor (TNF) superfamily are characterized by their ability to induce apoptosis once they bind in a homotrimeric manner to their cognate receptors. The receptor activator of nuclear factor-kappaB ligand (RANKL), a member of the TNF superfamily identified seven years ago, was originally described as a factor that induced osteoclastogenesis and dendritic cell survival. Recent observations indicate that a growth inhibitory and apoptosis-inducing activity is associated with RANKL, as is the case for other members of TNF superfamily. This review describes the possible mechanisms of induction of RANKL-induced growth inhibition/apoptosis and discusses the role of various components in RANKL-signaling in this phenomenon, including TNF receptor-associated factor (TRAF)-6, nuclear factor-kappaB (NF-kappaB), c-jun N-terminal kinase JNK), phosphatidylinositol-3 kinase (PI3K).
引用
收藏
页码:677 / 690
页数:14
相关论文
共 50 条
  • [1] Ranking the role of RANK ligand in apoptosis
    A. C. Bharti
    B. B. Aggarwal
    Apoptosis, 2004, 9 : 677 - 690
  • [2] Bone Biology and the Role of the RANK Ligand Pathway
    Murthy, Rashmi K.
    Morrow, P. K.
    Theriault, Richard L.
    ONCOLOGY-NEW YORK, 2009, 23 (14): : 9 - 15
  • [3] The role of RANK ligand/osteoprotegerin in rheumatoid arthritis
    Geusens, Piet
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (04) : 225 - 233
  • [4] RANKING AND RANK CORRELATION
    YANAGIMOTO, T
    OKAMOTO, M
    ANNALS OF MATHEMATICAL STATISTICS, 1968, 39 (05): : 1790 - +
  • [5] Antibody to rank ligand -: Overview of RANK ligand
    Fournier, P
    Ebetino, FH
    Bellahcène, A
    Castronovo, V
    Clezardin, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P23 - P24
  • [6] Role of the RANK ligand pathway in the regulation of bone remodeling
    Lacey, D.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S119 - S119
  • [7] RANK-ligand - Key role in rheumatic arthritis
    Ameri, Abdol A.
    OSTEOLOGIE, 2009, 18 (03) : 246 - 246
  • [8] Osteoprotegerin, rank and rank ligand
    Kurban, Sevil
    Mehmetoglu, Idris
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2007, 32 (04): : 178 - 184
  • [9] Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data
    Dempster, David W.
    Lambing, Cheryl L.
    Kostenuik, Paul J.
    Grauer, Andreas
    CLINICAL THERAPEUTICS, 2012, 34 (03) : 521 - 536
  • [10] RANK ligand
    Blair, J. M.
    Zheng, Y.
    Dunstan, C. R.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (06): : 1077 - 1081